BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V, Soofiyani SR, Kozhamzharova L, Sharifi-Rad J, Calina D, Cho WC. Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int 2022;22:257. [PMID: 35971151 DOI: 10.1186/s12935-022-02677-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Iqbal MJ, Javed Z, Herrera-bravo J, Sadia H, Anum F, Raza S, Tahir A, Shahwani MN, Sharifi-rad J, Calina D, Cho WC. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation. Cancer Cell Int 2022;22:354. [DOI: 10.1186/s12935-022-02777-7] [Reference Citation Analysis]
2 Zhou H, Yuan Y, Wang Z, Ren Z, Hu M, Lu J, Gao H, Pan C, Zhao W, Zhu B. Co-delivery of doxorubicin and quercetin by Janus Hollow Silica Nanomotors for overcoming multidrug resistance in breast MCF-7/Adr cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2022. [DOI: 10.1016/j.colsurfa.2022.130654] [Reference Citation Analysis]
3 Khairnar SI, Kulkarni YA, Singh K. Cardiotoxicity linked to anticancer agents and cardioprotective strategy. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01411-4] [Reference Citation Analysis]
4 Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, Islam MT, Sharifi-rad J, Calina D, Cho WC. Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02706-8] [Reference Citation Analysis]